Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
2.
Hansen. int ; 35(1): 53-56, 2010.
Article Dans Portugais | LILACS, SES-SP, SESSP-ILSLPROD, SES-SP, SESSP-ILSLACERVO, SES-SP | ID: lil-789330

Résumé

Após re-introdução no mercado, a Talidomida tornou-se a droga mais eficaz no tratamento do eritema nodoso hânsenico, além de opção terapêutica para diversas doenças, como mieloma múltiplo. Contudo, o crescente uso desta, associado a corticóides sistêmicos e quimioterápicos, resultou em aumento de efeitos adversos pouco reconhecidos, como trombose venosa profunda.


After being reintroduced in the market, thalidomide has become the most effective drug in the treatment of erythema nodosum leprosum and a therapeutic option for several diseases, such as multiple myeloma. However, its increasing use, combined with systemic steroids and chemotherapy has also increased little recognized adverse effects, such as deep vein thrombosis.


Sujets)
Humains , Mâle , Sujet âgé , Érythème noueux , Lèpre lépromateuse , Lèpre/complications , Lèpre/traitement médicamenteux , Thrombose veineuse/étiologie , Veine fémorale , Hormones corticosurrénaliennes/effets indésirables , Thalidomide/effets indésirables , Thrombose veineuse/diagnostic
SÉLECTION CITATIONS
Détails de la recherche